Stoke Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $21.1M | $238.9M | $144.9M |
| FY2022 | $71.2M | $256.1M | $113.6M |
| FY2023 | $68.8M | $228.3M | $191.4M |
| FY2024 | $42.5M | $271.6M | $128.0M |
| FY2025 | $66.0M | $418.4M | $84.2M |